F-star Therapeutics, Inc.

101 employees

F-Star Therapeutics is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Immmunotherapy

CNS

Pharmaceutical

oncology

cancer research

tetravalent bispecifics

cancer

immuno-oncology

bispecific antibodies

Biopharma

immunology

biotech

Date founded

2006

Funding rounds raised

Total raised

$22M

from 25 investors over 25 rounds

F-star Therapeutics, Inc. raised $15M on November 20, 2020

Investors: M Ventures, S.R. One Ltd, Atlas Venture and Aescap

F-star Therapeutics, Inc. raised $9.4M on October 23, 2013

Investors: TVM Life Science Management Inc, MP Healthcare Venture Management Inc, Aescap, Atlas Venture, S.R. One Ltd and M Ventures

F-star Therapeutics, Inc. raised $22M on April 13, 2011

Investors: MP Healthcare Venture Management Inc, TVM Life Science Management Inc, Aescap, Atlas Venture, S.R. One Ltd and M Ventures

F-star Therapeutics, Inc. raised $11M on January 6, 2010

Investors: MP Healthcare Venture Management Inc, TVM Life Science Management Inc, M Ventures, Atlas Venture and Aescap

F-star Therapeutics, Inc. raised $4.4M on November 28, 2007

Investors: Novo Holdings

F-star Therapeutics, Inc. raised $8.3M on September 10, 2007

Investors: Atlas Venture and Aescap

F-star Therapeutics, Inc. raised $2M on January 8, 2007

Investors: Atlas Venture